Shenzhen Salubris Pharmaceuticals Co Ltd
Company Profile
Business description
Shenzhen Salubris Pharmaceuticals Co Ltd is a pharmaceutical company dedicated to the research, development, and sale of medical products for cardiovascular diseases, cephalous antibiotics, and bone resorption inhibitors. Its products mainly focused on the areas of cardio-cerebral vascular disease, diabetes, and complications, anti-tumor, and orthopedics, Its business lines include high-end chemical drugs, biological drugs, and medical devices. Its businesses are located in China, the United States, Germany, France, and Japan, and other countries and regions.
Contact
No. 6009 Shennan Road
37th Floor, Main Building, Chegongmiao Lvjing Plaza
Futian District, Guangdong
Shenzhen518040
CHNT: +86 75583867888
Sector
Healthcare
Stock type
Defensive
Industry
Medical Instruments & Supplies
Fiscal Year End
31 December 2025
Employees
3,596
Stocks News & Analysis
stocks
Has the most hated company on the ASX 200 bounced back?
stocks
Amazon earnings: Good results, with AWS still a winner; fear on profitability guidance is overblown
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,922.00 | 77.00 | -0.86% |
| CAC 40 | 7,618.30 | 72.14 | 0.96% |
| DAX 40 | 23,741.61 | 315.64 | 1.35% |
| Dow JONES (US) | 43,920.62 | 210.36 | -0.48% |
| FTSE 100 | 9,099.34 | 33.47 | -0.37% |
| HKSE | 24,733.45 | 39.88 | -0.16% |
| NASDAQ | 20,904.37 | 254.24 | 1.23% |
| Nikkei 225 | 40,290.70 | 779.12 | -1.90% |
| NZX 50 Index | 12,684.04 | 139.70 | -1.09% |
| S&P 500 | 6,293.25 | 55.24 | 0.89% |
| S&P/ASX 200 | 8,663.70 | 79.10 | -0.90% |
| SSE Composite Index | 3,583.31 | 23.36 | 0.66% |